Clinical trial
Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease: A Multicenter Randomized Placebo-Controlled Trial
NCT07556718 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease: A Multicenter Randomized Placebo-Controlled Trial
- Lead sponsor
- University of Michigan
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 3, 2026
- Completion date
- December 31, 2029
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
quiescent crohn's disease (cd)